Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1996-07-26
1997-08-26
Fitzgerald, David L.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
4353201, 435325, 4352523, 43525233, C12N 1521, C12N 121
Patent
active
056610092
ABSTRACT:
Described are rapid and highly efficient procedures for the total synthesis of linear, double stranded DNA sequences in excess of about 200 base pairs in length, which sequences may comprise entire structural genes. Novel sequences are prepared from two or more DNA subunits provided with terminal regions comprising restriction endonuclease cleavage sites facilitating insertion of subunits into a selected vector for purposes of amplification during the course of the total assembly process. The total, finally-assembled sequences include at least one, and preferably two or more, unique restriction endonuclease cleavage site(s) at intermediate positions along the sequence, allowing for easy excision and replacement of subunits and the correspondingly facile preparation of multiple structural analogs of polypeptides coded for by the sequences. Manufactured genes preferably include codons selected from among alternative codons specifying the same amino acid on the basis of preferential expression in a projected host microorganism (e.g., E. coli) to be transformed. Illustrated is the preparation and expression of manufactured genes capable of directing synthesis of human immune and leukocyte interferons and of other biologically active proteinaceous products, which products differ from naturally-occurring forms in terms of the identity and/or relative position of one or more amino acids, and in terms of one or more biological and pharmacological properties but which substantially retain other such properties.
REFERENCES:
patent: 4237224 (1980-12-01), Cohen et al.
patent: 4264731 (1981-04-01), Shine
patent: 4273875 (1981-06-01), Manis
patent: 4293652 (1981-10-01), Cohen
patent: 4414150 (1983-11-01), Goeddel
patent: 4457867 (1984-07-01), Ishida
patent: 4652639 (1987-03-01), Stabinsky
patent: 4695623 (1987-09-01), Stabinsky
patent: 4762791 (1988-08-01), Goeddel et al.
patent: 4897471 (1990-01-01), Stabinsky
Agarwal et al., "Total synthesis of the gene for an alanine transfer ribonucleic acid from yeast," Nature, 227, pp. 27-34 (1970).
Aharonowitz et al., "The microbiological production of pharmaceuticals," Scientific American, 245, No. 3, pp. 141-152 (1981).
Alton et al., "Nucleotide sequence analysis of the chloramphenicol resistance transposon Tn9," Nature, 282, pp. 864-869 (1979).
BRL Restriction Endonuclease Reference Chart, pp. 164-168.
Campbell et al., "A microplaque reduction assay for human and mouse interferon," Can. J. Microbiol., 21, pp. 1247-1253 (1975).
Edge et al., "Total synthesis of a human leukocyte interferon gene," Nature, 292, pp. 756-762 (1981).
Goeddel et al., "Expression in Escherichia coli of chemically synthesized genes for human insulin," Proc. Natl. Acad. Sci. U.S.A., 76, No. 1, pp. 106-110 (1979).
Goeddel et al., "Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone," Nature, 281, pp. 544-548 (1979).
Goeddel et al., "Human leukocyte interferon produced by E. coli is biologically active," Nature, 287, pp. 411-416 (1980).
Goeddel et al., "Synthesis of human fibroblast interferon by E. coli," Nucleic Acids Research, 8, No. 18, pp. 4057-4074 (1980).
Goeddel et al., "The structure of eight distinct cloned human leukocyte interferon cDNAs," Nature, 290, pp. 20-26 (1981).
Gold et al., "Translational initiation in prokaryotes," Ann. Rev. Microbiol., 35, pp. 365-403 (1981).
Grantham et al., "Codon catalog usage and the genome hypothesis," Nucleic Acids Research, 8, No. 1, pp. r49-r62 (1980).
Grantham et al., "Codon frequencies in 119 individual genes confirm consistent choices of degenerate bases according to genome type," Nucleic Acids Research, 8, No. 9, pp. 1893-1912 (1980).
Grantham et al., "Codon catalog usage is a genome strategy modulated for gene expressivity," Nucleic Acids Research, 9, No. 1, pp. r43-r74 (1981).
Gray et al., "Expression of human immune interferon cNDA in E. coli and monkey cells," Nature, 295, pp. 503-508 (1982).
Inokuchi et al., "Primary structure of the ompF gene that codes for a major outer membrane protein of Escherichia coli," Nucleic Acids Research, 10, No. 21, pp. 6957-6968 (1982).
Itakura et al., "Expression in Escherichia coli of a chemically synthesized gene for the hormone somatostatin," Science, 198, pp. 1056-1063 (1977).
Khorana, "Total synthesis of a gene," Science, 203, pp. 614-625 (1979).
Rinderknecht et al., "Natural human interferon-.gamma. complete amino acid sequence and determination of sites of glycosylation," The Journal of Biological Chemistry, 259, No. 11, pp. 6790-6797 (1984).
Shine et al., "Expression of cloned .beta.-endorphin gene sequences by Escherichia coli, Nature", 285, pp. 456-461 (1980).
Simonsen et al., "Plamid-directed synthesis of human immune interferon in E. coli and monkey cells," 3-Biochem. Genetics, 98, 1188C, p. 115 (1983).
Stebbing et al., "Pre-clinical assessment of biological properties of recombinant DNA derived human interferons," A.P. Bollon, ed., CRC Press, pp. 1-111, undated.
Stewart, The Interferon System, 2d ed., Springer-Verlag/Wien, New York, entire volume, (1981).
Streuli et al., "Target cell specificity of two species of human interferon-.alpha. produced in Escherichia coli and of hybrid molecules derived from them," Proc. Natl. Acad. Sci. U.S.A., 78, No. 5, pp. 2848-2852 (1981).
Tanaka et al., "Expression in Escherichia coli of a chemically synthesized gene for a human immune interferon," 3-Biochem. Genetics, 98, p. 135 (1983).
Ullrich et al., "Rat insulin genes: construction of plasmids containing the coding sequences," Science, 196, pp. 1313-1319 (1977).
Vilcek, "The importance of having gamma," Interferon, 4, Academic Press, pp. 129-135 (1982).
Wallace et al., "Directed deletion of a yeast transfer RNA intervening sequence," Science, 209, pp. 1196-1200, (1983).
Waterman, "Multiple sequence alignment by consensus," Nucleic Acids Research, 14, No. 22, pp. 9095-9102 (1986).
Weck et al., "Comparison of the antiviral activities of various cloned human interferon.alpha. subtypes in mammalian cell cultures," J. gen. Virol., 57, pp. 233-237 (1981).
Weck et al., "Antiviral activities of hybrids of two major human leukocyte interferons," Nucleic Acids Research, 9, No. 22, pp. 6153-6166 (1981).
Weissmann et al., "Structure and expression of human alpha-interferon genes," Interferons, Academic Press, Inc., pp. 295-326 (1982).
Weissmann, "Reversed genetics," Trends in Biochemical Science, pp. 109-111 (1978).
Amgen Inc.
Fitzgerald David L.
LandOfFree
Recombinant production of consensus human leukocyte interferon does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant production of consensus human leukocyte interferon, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant production of consensus human leukocyte interferon will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1987530